Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs. placebo in outpatients with major depressive disorder

  • R. L. Borison
  • , D. Sinha
  • , J. W. Albrecht
  • , S. Geber
  • , B. I. Diamond

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)186-189
Number of pages4
JournalPsychopharmacology Bulletin
Volume25
Issue number2
StatePublished - 1989

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this